Inicio › Colitis ulcerativa › Illinois › Chicago
Ensayos clínicos de Colitis ulcerativa en Chicago, IL
13 estudios para Colitis ulcerativa buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ReclutandoFase 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
ReclutandoFase 2
- Rush University Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutandoFase 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
ReclutandoFase 2
- Northwestern University, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ReclutandoFase 2
- University of Chicago Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
ReclutandoFase 2
- University of Chicago Medical Center, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ReclutandoFase 2
- Site 038, Chicago
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
ReclutandoFase 3
- University of Chicago Medical Center /ID# 271588, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ReclutandoEstudio observacional
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutandoFase 3
- Rush University Medical Center - Site Number: 8400015, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Reclutando
- University of Chicago, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Reclutando
- University of Chicago Medicine, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
ReclutandoFase 2
- Northwestern University, Chicago
Más información sobre Colitis ulcerativa en MedlinePlus
Ensayos de Colitis ulcerativa en otras ciudades
- Orlando, FL21 estudios
- New York City, NY21 estudios
- Miami, FL20 estudios
- Houston, TX14 estudios
- San Diego, CA13 estudios
- Tacoma, WA13 estudios
- St. Louis, MO13 estudios
- Tyler, TX13 estudios
- San Antonio, TX13 estudios
- Colorado Springs, CO12 estudios
- Boston, MA12 estudios
- Los Angeles, CA11 estudios
Otros estudios en Chicago
- Cáncer de seno59 estudios
- Cáncer de pulmón de células no pequeñas59 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer de próstata45 estudios
- Cáncer de pulmón43 estudios
- Cáncer metastásico42 estudios
- Obesidad40 estudios
- Cáncer de ovario36 estudios
- Cáncer del colon y del recto32 estudios
- Accidente cerebrovascular31 estudios
- Carcinoma de células escamosas de cabeza y cuello29 estudios
- Sobrepeso29 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.